SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Shire plc Reports Positive Phase 2 Study Met Primary End Point for Investigative Use of Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) in Adults With Binge Eating Disorder